● Single award · contract
License Pathogen Reduction Technology (Prt) for Red Blood Cell (Rbc) Components to Reduce the Risk of…
A single federal award, with both ends of the trail linked.
$65.4M
total award value
2024
action date
84 mo
period
75A50124C00046
PIID
Description
License Pathogen Reduction Technology (Prt) for Red Blood Cell (Rbc) Components to Reduce the Risk of Transfusion-Transmitted Infection (Tti) by Recognized, Emerging, Epidemic, and Endemic Pathogens That Is Capable of Treating Over 10 Million RBC Com
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceCalifornia →
CategoryPSC 6505NAICS 541714
Competed?Not recorded✓ from source
Total (exact)$65,358,564
More from Department of Health and Human Services
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
awarded 2022$71.7B
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; figures we calculate are ≈ computed; links we infer (corporate parents, districts, competitors, connections between records) are ≈ inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.